Dexlansoprazole Market Insights, Global Outlook and Forecast 2022-2028
Dexlansoprazole Market Insights, Global Outlook and Forecast 2022-2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
The latest research study released by Market IntelliX evaluates market size and forecasts of Dexlansoprazole in global, including the following market information:
Global Dexlansoprazole Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dexlansoprazole Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dexlansoprazole companies in 2021 (%)
The global Dexlansoprazole market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Dexlansoprazole manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Dexlansoprazole Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, by Type, 2021 (%)
30 mg
60 mg
Global Dexlansoprazole Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, by Application, 2021 (%)
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
Global Dexlansoprazole Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dexlansoprazole revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dexlansoprazole revenues share in global market, 2021 (%)
Key companies Dexlansoprazole sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dexlansoprazole sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Dexlansoprazole Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dexlansoprazole Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dexlansoprazole Overall Market Size
2.1 Global Dexlansoprazole Market Size: 2021 VS 2028
2.2 Global Dexlansoprazole Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dexlansoprazole Sales: 2017-2028
3 Company Landscape
3.1 Top Dexlansoprazole Players in Global Market
3.2 Top Global Dexlansoprazole Companies Ranked by Revenue
3.3 Global Dexlansoprazole Revenue by Companies
3.4 Global Dexlansoprazole Sales by Companies
3.5 Global Dexlansoprazole Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dexlansoprazole Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dexlansoprazole Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dexlansoprazole Players in Global Market
3.8.1 List of Global Tier 1 Dexlansoprazole Companies
3.8.2 List of Global Tier 2 and Tier 3 Dexlansoprazole Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dexlansoprazole Market Size Markets, 2021 & 2028
4.1.2 30 mg
4.1.3 60 mg
4.2 By Type - Global Dexlansoprazole Revenue & Forecasts
4.2.1 By Type - Global Dexlansoprazole Revenue, 2017-2022
4.2.2 By Type - Global Dexlansoprazole Revenue, 2023-2028
4.2.3 By Type - Global Dexlansoprazole Revenue Market Share, 2017-2028
4.3 By Type - Global Dexlansoprazole Sales & Forecasts
4.3.1 By Type - Global Dexlansoprazole Sales, 2017-2022
4.3.2 By Type - Global Dexlansoprazole Sales, 2023-2028
4.3.3 By Type - Global Dexlansoprazole Sales Market Share, 2017-2028
4.4 By Type - Global Dexlansoprazole Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Dexlansoprazole Market Size, 2021 & 2028
5.1.2 Gastroesophageal Reflux Disease
5.1.3 Heal Erosive Esophagitis
5.2 By Application - Global Dexlansoprazole Revenue & Forecasts
5.2.1 By Application - Global Dexlansoprazole Revenue, 2017-2022
5.2.2 By Application - Global Dexlansoprazole Revenue, 2023-2028
5.2.3 By Application - Global Dexlansoprazole Revenue Market Share, 2017-2028
5.3 By Application - Global Dexlansoprazole Sales & Forecasts
5.3.1 By Application - Global Dexlansoprazole Sales, 2017-2022
5.3.2 By Application - Global Dexlansoprazole Sales, 2023-2028
5.3.3 By Application - Global Dexlansoprazole Sales Market Share, 2017-2028
5.4 By Application - Global Dexlansoprazole Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Dexlansoprazole Market Size, 2021 & 2028
6.2 By Region - Global Dexlansoprazole Revenue & Forecasts
6.2.1 By Region - Global Dexlansoprazole Revenue, 2017-2022
6.2.2 By Region - Global Dexlansoprazole Revenue, 2023-2028
6.2.3 By Region - Global Dexlansoprazole Revenue Market Share, 2017-2028
6.3 By Region - Global Dexlansoprazole Sales & Forecasts
6.3.1 By Region - Global Dexlansoprazole Sales, 2017-2022
6.3.2 By Region - Global Dexlansoprazole Sales, 2023-2028
6.3.3 By Region - Global Dexlansoprazole Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Dexlansoprazole Revenue, 2017-2028
6.4.2 By Country - North America Dexlansoprazole Sales, 2017-2028
6.4.3 US Dexlansoprazole Market Size, 2017-2028
6.4.4 Canada Dexlansoprazole Market Size, 2017-2028
6.4.5 Mexico Dexlansoprazole Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Dexlansoprazole Revenue, 2017-2028
6.5.2 By Country - Europe Dexlansoprazole Sales, 2017-2028
6.5.3 Germany Dexlansoprazole Market Size, 2017-2028
6.5.4 France Dexlansoprazole Market Size, 2017-2028
6.5.5 U.K. Dexlansoprazole Market Size, 2017-2028
6.5.6 Italy Dexlansoprazole Market Size, 2017-2028
6.5.7 Russia Dexlansoprazole Market Size, 2017-2028
6.5.8 Nordic Countries Dexlansoprazole Market Size, 2017-2028
6.5.9 Benelux Dexlansoprazole Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Dexlansoprazole Revenue, 2017-2028
6.6.2 By Region - Asia Dexlansoprazole Sales, 2017-2028
6.6.3 China Dexlansoprazole Market Size, 2017-2028
6.6.4 Japan Dexlansoprazole Market Size, 2017-2028
6.6.5 South Korea Dexlansoprazole Market Size, 2017-2028
6.6.6 Southeast Asia Dexlansoprazole Market Size, 2017-2028
6.6.7 India Dexlansoprazole Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Dexlansoprazole Revenue, 2017-2028
6.7.2 By Country - South America Dexlansoprazole Sales, 2017-2028
6.7.3 Brazil Dexlansoprazole Market Size, 2017-2028
6.7.4 Argentina Dexlansoprazole Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dexlansoprazole Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Dexlansoprazole Sales, 2017-2028
6.8.3 Turkey Dexlansoprazole Market Size, 2017-2028
6.8.4 Israel Dexlansoprazole Market Size, 2017-2028
6.8.5 Saudi Arabia Dexlansoprazole Market Size, 2017-2028
6.8.6 UAE Dexlansoprazole Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Dexlansoprazole Major Product Offerings
7.1.4 Takeda Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Key News
7.2 Cardinal Health
7.2.1 Cardinal Health Corporate Summary
7.2.2 Cardinal Health Business Overview
7.2.3 Cardinal Health Dexlansoprazole Major Product Offerings
7.2.4 Cardinal Health Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.2.5 Cardinal Health Key News
7.3 Suzhou Homesun Pharmaceutical
7.3.1 Suzhou Homesun Pharmaceutical Corporate Summary
7.3.2 Suzhou Homesun Pharmaceutical Business Overview
7.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Major Product Offerings
7.3.4 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.3.5 Suzhou Homesun Pharmaceutical Key News
7.4 Frontida
7.4.1 Frontida Corporate Summary
7.4.2 Frontida Business Overview
7.4.3 Frontida Dexlansoprazole Major Product Offerings
7.4.4 Frontida Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.4.5 Frontida Key News
7.5 Zhendong Group
7.5.1 Zhendong Group Corporate Summary
7.5.2 Zhendong Group Business Overview
7.5.3 Zhendong Group Dexlansoprazole Major Product Offerings
7.5.4 Zhendong Group Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.5.5 Zhendong Group Key News
7.6 Ouya Pharmaceutical
7.6.1 Ouya Pharmaceutical Corporate Summary
7.6.2 Ouya Pharmaceutical Business Overview
7.6.3 Ouya Pharmaceutical Dexlansoprazole Major Product Offerings
7.6.4 Ouya Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.6.5 Ouya Pharmaceutical Key News
7.7 Heron Pharmaceutical
7.7.1 Heron Pharmaceutical Corporate Summary
7.7.2 Heron Pharmaceutical Business Overview
7.7.3 Heron Pharmaceutical Dexlansoprazole Major Product Offerings
7.7.4 Heron Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.7.5 Heron Pharmaceutical Key News
7.8 Sailong
7.8.1 Sailong Corporate Summary
7.8.2 Sailong Business Overview
7.8.3 Sailong Dexlansoprazole Major Product Offerings
7.8.4 Sailong Dexlansoprazole Sales and Revenue in Global (2017-2022)
7.8.5 Sailong Key News
8 Global Dexlansoprazole Production Capacity, Analysis
8.1 Global Dexlansoprazole Production Capacity, 2017-2028
8.2 Dexlansoprazole Production Capacity of Key Manufacturers in Global Market
8.3 Global Dexlansoprazole Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dexlansoprazole Supply Chain Analysis
10.1 Dexlansoprazole Industry Value Chain
10.2 Dexlansoprazole Upstream Market
10.3 Dexlansoprazole Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dexlansoprazole Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Dexlansoprazole Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|